• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes

byMinjee Kim
December 2, 2021
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 diabetes.

2. ACE-inhibitors and ARBs were associated with a reduced risk of type 2 diabetes, while beta-blockers and thiazide diuretics increased the risk.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Management of the microvascular and macrovascular complications of type 2 diabetes often consists of controlling comorbid elevated blood pressures. However, it is not known whether controlling hypertension would decrease the risk for developing new-onset diabetes. This meta-analysis used patient data from previous randomized controlled trials of antihypertensive medications and evaluated the risk of developing type 2 diabetes. The study found that a 5-mmHg reduction in blood pressure was associated with a reduced risk for new-onset type 2 diabetes. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) were the most effective antihypertensives for reducing diabetes risk, while beta-blockers and thiazide diuretics increased the risk for diabetes. Calcium channel blockers did not have a significant effect on the development of diabetes. A limitation of this study includes the inability to determine whether low blood pressure is associated with a lower risk of diabetes or if certain medications improve diabetes risk through their own pharmacological mechanisms. For example, ACE inhibitors may lower inflammation in the body, which could help protect against diabetes not necessarily linked to hypertension. Nonetheless, this study illustrates the potential benefit of controlling high blood pressure on the risk of diabetes.

Click to read the study in the Lancet

RELATED REPORTS

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

Oral semaglutide reduces cardiovascular event rates in high-risk patients

Hypotension- and hypertension-avoidance strategies may yield similar neurocognitive outcomes following noncardiac surgery

Click to read an accompanying editorial in the Lancet

Relevant Reading:  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

In-Depth [meta-analysis]: This meta-analysis obtained randomized controlled trial data comparing antihypertensives in primary and secondary prevention programs from the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC). Patients with pre-existing diabetes were excluded. The final cohort included 145 939 patients (60.6% men) across 19 trials with at least 1000 persons-years of follow-up data. Median follow-up was 4.5 years. There were 9883 patients diagnosed with diabetes during this follow-up time. This was calculated to be 16.44 (95% CI 16.01-16.87) events per 1000 person-years in the comparator group and 15.94 (15.47-16.42) in the intervention group. The comparator group was made up of placebo groups and less effective antihypertensives in the RCTs. A 5-mmHg reduction in systolic blood pressure resulted in an 11% reduction in risk for diabetes (hazard ratio 0.89 [95% CI 0.84-0.95]). In terms of specific antihypertensive classes, beta-blockers (relative risk 1.48 [1.27-1.74]) and thiazide diuretics (RR 1.20 [1.07-1.35]) were found to increase the risk of type 2 diabetes. In contrast, ACE inhibitors (RR 0.84 [0.76-0.93] and ARBs (RR 0.84 [0.76-0.92]) were found to reduce the risk of diabetes compared to placebo. There was no difference in risk between calcium channel blockers and placebo.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ACE inhibitorsangiotensin receptor blocker (ARB)antihypertensivesbeta blockerblood pressureblood pressure controlcalcium channel blocker (CCB)diabetesdiabetes mellitusdiabetes riskhypertensionhypertension controlhypertensive medicationssystolic blood pressurethiazide diuretictype 2 diabetesType 2 Diabetes Mellitus
Previous Post

Socioeconomic and ethnic inequalities are associated with greater risks for adverse pregnancy outcomes

Next Post

Wellness Check: Nutrition

RelatedReports

Compliance-linked incentives increase infant immunizations rates in rural India
Endocrinology

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

June 16, 2025
Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients
Cardiology

Oral semaglutide reduces cardiovascular event rates in high-risk patients

June 5, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Chronic Disease

Hypotension- and hypertension-avoidance strategies may yield similar neurocognitive outcomes following noncardiac surgery

June 14, 2025
Increased number of daily steps linked with decreased mortality in older women
Chronic Disease

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

May 29, 2025
Next Post
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Wellness Check: Nutrition

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

High-titre convalescent plasma therapy not effective against severe COVID-19 pneumonia

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
  • Frailty scores alone may be poor predictors of intensive care admission or hospital stay duration
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.